Navigation Links
REGiMMUNE to present GvHD data at the 50th ASH Annual Meeting
Date:12/5/2008

Mountain View, CA December 5, 2008 REGiMMUNE Corporation, a privately held biopharmaceutical company focused on developing technologies and products for immune disorders, will present preclinical data on the company's potential therapeutic treatment for Graft versus Host Disease (GvHD) at the American Society of Hematology Annual Meeting being held December 6 through 9 in San Francisco, California. REGiMMUNE is developing KRN7000 (RGI-2001) as a new immunosuppressant for GvHD associated with stem cell transplantation. Two posters will be presented at ASH on the evenings of Sunday December 7 and Monday December 8, respectively.

Abstract/Poster II-426
Sunday, December 7: 6:00 PM - 8:00 PM
Donor-Specific Tolerance Induction through Expansion of DCregs and Tregs by a Liposomal Formulation of KRN7000 (RGI-2001)

Abstract/Poster III-582
Monday, December 8: 5:30 PM - 7:30 PM
A Liposomal Formulation of KRN7000 (RGI-2001) Potently Reduces GvHD Lethality through the Expansion of CD4+Foxp3+ Regulatory T cells in Murine Models.

"We are delighted to present our progress on RGI-2001 development at the 50th ASH Annual Meeting," said Mr. Haru Morita, President and Chief Executive Officer, REGiMMUNE. "This is a great opportunity to provide an update on our pre-IND stage product candidate, RGI-2001, which is in a preclinical study for GvHD associated with bone marrow transplantation. The company is also developing RGI-2001 for solid organ transplantation. Our mission is to develop novel therapies for immune disorders including allergies, autoimmune diseases and transplantation. We believe the success of RGI-2001 will be the first demonstration of the promise of our proprietary technology and of the company's significant development capabilities."


'/>"/>

Contact: Debra Bannister
530-676-8001
REGiMMUNE
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
2. Aflac Incorporated To Present at the Goldman Sachs U.S. Financial Services Conference 2008
3. Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
4. MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
5. Zevalin Data to be Presented at ASH 2008
6. MAP Pharmaceuticals to Present at the 2008 RBC Capital Markets Healthcare Conference
7. Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis
8. Cardium Announces Investor Presentation and Corporate Update Webcast
9. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
10. LCA-Vision to Present at RBC Capital Markets 2008 Healthcare Conference
11. Quark Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Today, Coastal Healthcare Administrators officially announced ... the first time since its inception in ... will be assuming responsibilities and provider contracts ... Medical Care. ,, Operating on a ... working relationships with all network physicians, ancillary ...
(Date:12/15/2009)... gynaecologist or midwife are generally associated with different ... so much more. Women, doctors and midwives are ... dialogue about sexual health, reveals a thesis from ... Sweden. , Many young women see sex as ... aged 23-29 answered questions about their sex lives, ...
(Date:12/15/2009)... DURHAM, N.C. Scientists seeking to understand how to ... a major roadblock. It turns out that the immune ... manufacture powerful HIV-blocking antibodies but at the same ... sure these cells are eliminated before they have a ... potentially protective neutralizing antibody against a viral disease is ...
(Date:12/15/2009)... about-face, the secretive Central Intelligence Agency has requested documents from ... them from the CIA itself under the Freedom of Information ... ... 15, 2009 -- In a bizarre about-face, the secretive Central ... though the writer had earlier obtained them from the CIA ...
(Date:12/15/2009)... deemed safer than wood fiber , , TUESDAY, Dec. 15 (HealthDay ... arm in a fall are much lower on playgrounds with ... new research has found. , Researchers at the Hospital for ... playground surfaces of either granite sand or engineered wood fiber. ... Medicine . , The risk of a broken arm resulting ...
Breaking Medicine News(10 mins):Health News:Coastal Healthcare Administrators Expands Provider Network to Santa Clara County 2Health News:More about sex and relationships needed at gynecological visits 2Health News:Biological catch-22 prevents induction of antibodies that block HIV 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3
... scientists which is reported to be ten times more powerful ... This brings a manned mission to planet Mars closer to ... to accelerate a beam of ions away from the spacecraft ... ESA’s Electric Propulsion Laboratory in the Netherlands have shown that ...
... the latest Journal of Advanced Nursing says expresses deep concern ... the nursing profession. // ,Professor Jill Macleod Clark ... profession to bring about change, the basic problems identified by ... Bendall's paper, which is reprinted in the 30th Anniversary Issue ...
... how the brain functions and converts raw data into ... Zanvyl Krieger Mind/Brain Institute reveals the detailed process in ... the brains visual center is activated and tries to ... converted in the form of an image, which the ...
... disease (cervical cancer) that has been haunting the world. The ... vaccine, // shown to offer protection against 70% of ... (HPV) to the U.S. Food and Drug Administration (FDA). ... approved for use in Europe and other countries excluding the ...
... pan masala and tobacco products near hospitals and educational institutions by ... only from beyond 500 meters from such institutions, according to the ... ensure that this is strictly adhered to. ,The ... the product due its low price and easy availability. Children are ...
... a professor in Penn's Department of Psychology and researcher ... which reported that people couldn’t resist a pretty face. ... positive trait. Participants were given a fraction of a ... ,Participants took very little time in judging attractiveness knowing ...
Other Medicine News:Health News:What nurses learn is not what they practice 2Health News:Understanding “The Brain 2Health News:Cervical Cancer Vaccine Show Promise In Prevention 2Health News:Are pretty faces associated with positive trait? 2
(Date:12/15/2009)... Calif., Dec. 15 Genomic Health, Inc. (Nasdaq: ... studies on its Onco type DX® breast cancer ... to predict the likelihood of chemotherapy benefit and recurrence ... were presented at the 32nd Annual CTRC-AACR San Antonio ... in San Antonio, TX. ,, "The breadth of data ...
(Date:12/15/2009)... Resources, one of the world,s leading research and ... that an overall survival benefit would be the ... oncologists in their decision to prescribe a novel ... breast cancer. ,, The new Special European Physician ... in Targeted Therapies in Breast Cancer: A Clinician ...
(Date:12/15/2009)... December 15 Bend Research Inc. announced,today that ... for HPMCAS, an,excipient used in technologies developed by the ... , Bend Research clients may ... HPMCAS for regulatory filings with the FDA, Bend Research ... about this new development and know it will assist ...
Breaking Medicine Technology:Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient 2MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 4666 1MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 4666 2Maybe Men Arent So Picky After All 50309 1Maybe Men Arent So Picky After All 50309 2News from the Latest Issue of Molecular Medicine Kicking The Habit It 26apos 3Bs In The Genes 50305 1News from the Latest Issue of Molecular Medicine Kicking The Habit It 26apos 3Bs In The Genes 50305 2
Straight shafts with polished finish. Teeth: 0.12 mm. Tying platform: 5.0 mm. Wide Serrated....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Straight shafts with 1 x 2 teeth and 6 mm tying platform. Wide serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and serrated handle with polished finish....
Medicine Products: